• Explore /
  • Poster
  • / Salvage ipilimumab plus nivolumab in advanced hepatocellular carcinoma after prior anti-PD-(L)1 blockade.

Salvage ipilimumab plus nivolumab in advanced hepatocellular carcinoma after prior anti-PD-(L)1 blockade.

Abstract Poster

Authors

null

Stephanie Leigh Alden

Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, Baltimore, MD

Stephanie Leigh Alden , Mir Lim , Chester Kao , Daniel Shu , Amit G. Singal , Anne M. Noonan , Paige Griffith , Marina Baretti , Won Jin Ho , Ihab R. Kamel , Mark Yarchoan , David Hsiehchen

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Hepatobiliary Cancer - Advanced/Metastatic Disease

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 4091)

DOI

10.1200/JCO.2023.41.16_suppl.4091

Abstract #

4091

Poster Bd #

412

Abstract Disclosures

Similar Posters

First Author: Timothy J. Brown

First Author: Jamie Grossman

First Author: Hong Jae Chon

First Author: Leijuan Gan